Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Anyone can

<Just how can a company sign with TPL when ownership is being questioned. >

IMHO the ownership question has nothing to do with the licensing. I do not believe there is any dispute that Alliacense has been granted the authority to market/license the MMP. Ownership has to do with who controls the funds after PDS makes a distribution. 50% to PTSC and 50% to ? Corrections welcomed. Opty

Share
New Message
Please login to post a reply